FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adriaan Voors

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Anatomy

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Solmaz Assa; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Anneke C Muller Kobold; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients.
Peter van der Meer; John G Cleland; Gad Cotter; Beth A Davison; Michael M Givertz; Hans L Hillege; George A Mansoor; Barry M Massie; Marco Metra; Christopher M O'Connor; Piotr Ponikowski; Douwe Postmus; John R Teerlink; Adriaan A Voors
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adriaan Voors (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Solmaz Assa; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Anneke C Muller Kobold; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients.
Clinical research in cardiology : official journal of the German Cardiac Society 2013;102(6):439-45.
2013: Peter van der Meer; John G Cleland; Gad Cotter; Beth A Davison; Michael M Givertz; Hans L Hillege; George A Mansoor; Barry M Massie; Marco Metra; Christopher M O'Connor; Piotr Ponikowski; Douwe Postmus; John R Teerlink; Adriaan A Voors
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Journal of the American College of Cardiology 2013;61(19):1973-81.
2013: Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European heart journal 2013;34(19):1424-31.
2013: Dirk J van Veldhuisen; Adriaan A Voors; Arno W Hoes; Tiny Jaarsma; Gerard C M Linssen; Walter J Paulus; Jan G P Tijssen; Wiek H van Gilst; Hans L Hillege
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
Journal of the American College of Cardiology 2013;61(14):1498-506.
2013: Ijsbrand T Klip; Dirk J Lok; Lech Polonski; Piotr Ponikowski; Piotr Rosentryt; Ainhoa Torrens; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors; Waldemar Banasiak; Josep Comin-Colet; Cristina Enjuanes; Ewa A Jankowska
Iron deficiency in chronic heart failure: an international pooled analysis.
American heart journal 2013;165(4):575-582.e3.
2013: Mihai Gheorghiade; Stephen J Greene; Phillip D. Levy; Catherine N Marti; Marco Metra; Bertram Pitt; Piotr Ponikowski; Lothar Roessig; Hani N Sabbah; Naoki Sato; Johannes-Peter Stasch; Adriaan A Voors; Michael Böhm; John C Burnett; Javed Butler; Umberto Campia; John G F Cleland; Sean P Collins; Gregg C Fonarow
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
Heart failure reviews 2013;18(2):123-34.
2013: Adriaan A Voors
Trial data resolve gaps in evidence-based treatment.
Nature reviews. Cardiology 2013;10(2):67-8.
2013: Marco Metra; Peter S Pang; Piotr Ponikowski; Margaret F Prescott; Rajnish Saini; Christoph Schumacher; Thomas Severin; John R Teerlink; Sam L Teichman; Angelo Trapani; Elaine Unemori; Adriaan A Voors; Karl Werdan; Kirkwood F Adams; Christopher A Bush; Gad Cotter; Beth A Davison; Maria I Dorobantu; Christopher Edwards; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Liliana Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
Journal of the American College of Cardiology 2013;61(2):196-206.
2013: John R Teerlink; Sam L Teichman; Angelo Trapani; Elaine Unemori; Adriaan A Voors; Karl Werdan; Kirkwood F Adams; Christopher A Bush; Gad Cotter; Beth A Davison; Maria I Dorobantu; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Liliana Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Marco Metra; Peter S Pang; Piotr Ponikowski; Rajnish Saini; Christoph Schumacher; Thomas M Severin
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Lancet 2013;381(9860):29-39.
2012: Suzan Willemsen; Jasper W L Hartog; Hans L Hillege; Tiny Jaarsma; Joline F Roze; Casper Schalkwijk; Iwan C C van der Horst; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
American heart journal 2012;164(5):742-749.e3.
2012: Faiez Zannad; George L Bakris; Johann Bauersachs; Farzin Beygui; Alain Cohen-Solal; Gerasimos S Filippatos; Wendy Gattis-Stough; Mihai Gheorghiade; Aldo P Maggioni; Ziad A Massy; John J V McMurray; Robert J Mentz; Christopher M O'Connor; Atul Pathak; Ileana L Piña; Patrick Rossignol; Luis M Ruilope; Hani N Sabbah; Domenic A Sica; Allan D Struthers; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Bertram Pitt
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
European heart journal 2012;33(22):2782-95.
2012: Yoran M Hummel; Marco Metra; Johannes S Sipkens; Dirk J van Veldhuisen; Silvia Bugatti; Kevin Damman; Jasper W L Hartog; Suzan Willemsen; Adriaan A Voors
Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart failure.
The American journal of cardiology 2012;110(9):1336-41.
2012: Laura M G Meems; Willem P T Ruifrok; Herman H W Silljé; Wiek H van Gilst; Adriaan A Voors; Megan V Cannon; Hasan Mahmud; Rudolf A de Boer
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
The Journal of steroid biochemistry and molecular biology 2012;132(3-5):282-9.
2012: G Michael Felker; Gregg C Fonarow; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; John J V McMurray; Marco Metra; Stefan D Anker; Paul W Armstrong; Dan Atar; Javed Butler; Robert M Califf; Kenneth Dickstein; Randall C Starling; W H Wilson Tang; Richard W Troughton; Adriaan A Voors; Christopher M O'Connor
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
European journal of heart failure 2012;14(11):1257-64.
2012: Thomas F Lüscher; Frank Ruschitzka; Wiek H van Gilst; Ulf Landmesser; Adriaan A Voors; Dirk J van Veldhuisen
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing.
European journal of heart failure 2012;14(10):1075-82.
2012: Solmaz Assa; Paul E de Jong; Yoran M Hummel; Johanna Kuipers; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(10):1615-23.
2012: Marco Metra; Gad Cotter; Livio Dei Cas; Mihai Gheorghiade; Adriaan A Voors
The role of the kidney in heart failure.
European heart journal 2012;33(17):2135-42.
2012: Adriaan A Voors; Dirk J van Veldhuisen
Why do drugs for acute heart failure fail?
European journal of heart failure 2012;14(9):955-6.
2012: Lennaert Kleijn; Wiek H van Gilst; Adriaan A Voors; Dirk J van Veldhuisen; Anne M S Belonje; Rudolf A de Boer; Sudip Ghosh; Hans L Hillege; Tiny Jaarsma; Joseph Kim; Peter van der Meer
Inflammation and anaemia in a broad spectrum of patients with heart failure.
Heart (British Cardiac Society) 2012;98(16):1237-41.
2012: Mattia A E Valente; Kevin Damman; Peter H J M Dunselman; Hans L Hillege; Adriaan A Voors
Urinary proteins in heart failure.
Progress in cardiovascular diseases 2012;55(1):44-55.
2012: Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Daniel Wojdyla; Robert J Mentz; Marco Metra; Karen Chiswell; John G Cleland; Gad Cotter; Beth A Davison; Mona Fiuzat; Michael M Givertz; George A Mansoor; Barry M Massie
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
European journal of heart failure 2012;14(6):605-12.
2012: Solmaz Assa; Judith J Dasselaar; Paul E de Jong; Riemer H J A Slart; René A Tio; Adriaan A Voors; Casper F M Franssen
Comparison of cardiac positron emission tomography perfusion defects during stress induced by hemodialysis versus adenosine.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(6):862-4.
2012: Marco Metra; Adriaan A Voors
The puzzle of kidney dysfunction in heart failure: an introduction.
Heart failure reviews 2012;17(2):129-31.
2012: John R Teerlink; Scott Thomson; Paul D Varosy; Adriaan A Voors; Denise Wolko; Michael R Zile; Marco Metra; Alan B Miller; Jay P Mohr; Christopher M O'Connor; Ileana L Piña; Piotr Ponikowski; Christina M Salerno; Peter E Carson; John G F Cleland; Gad Cotter; Beth A Davison; Paul Delucca; Howard Dittrich; Michael M Givertz; Paul J Hauptman; Vicente J Iragui; David H Lovett; George A Mansoor; Barry M Massie
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(3):233-44.
2012: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
Current and novel renal biomarkers in heart failure.
Heart failure reviews 2012;17(2):241-50.
2012: Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.
Heart failure reviews 2012;17(2):221-8.
2012: Piotr Ponikowski; Thomas Severin; John R Teerlink; Sam L Teichman; Elaine Unemori; Adriaan A Voors; G Michael Felker; Gerasimos Filippatos; Barry Greenberg; Marco Metra; Guenther Mueller-Velten; Gad Cotter; Beth A Davison
Design of the RELAXin in acute heart failure study.
American heart journal 2012;163(2):149-55.e1.
2011: Youlan L Gu; Hans L Hillege; Serge Masson; Joachim Struck; Tarcisio Vago; Ad F M van den Heuvel; Dirk J van Veldhuisen; Adriaan A Voors; Felix Zijlstra; Stefan D Anker; Bart J G L de Smet
Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(12):1069-76.
2011: Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Daniel Bloomfield; John Cleland; Gad Cotter; Beth A Davison; Paul Delucca; Howard C Dittrich; Mona Fiuzat; Kenji Fujita; Michael M Givertz; Gang Jia; Carlo Lombardi; George Mansoor; Barry M Massie; Marco Metra
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
Circulation. Heart failure 2011;4(6):724-32.
2011: Michael Böhm; Peter Bramlage; Jean-Marie Ketelslegers; Stephan H Schirmer; Eva Turgonyi; Adriaan A Voors; Faiez Zannad
Biomarkers: optimizing treatment guidance in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(11):973-81.
2011: Gerard C M Linssen; Michiel Rienstra; Isabelle C Van Gelder; Hans L Hillege; Tiny Jaarsma; Adriaan A Voors; Dirk J van Veldhuisen
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
European journal of heart failure 2011;13(10):1111-20.
2011: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
The cardiorenal syndrome in heart failure.
Progress in cardiovascular diseases 2011;54(2):144-53.
2011: Adriaan A Voors; Gadi Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Marco Metra; Piotr Ponikowski; John R Teerlink; Sam L Teichman; Elaine Unemori
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF.
European journal of heart failure 2011;13(9):961-7.
2011: Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry Greenberg; Marco Metra; Piotr Ponikowski; Hengrui Sun; John R Teerlink; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Li Chen; Gad Cotter; Gary G Koch
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(9):745-53.
2011: Marco Metra; Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Beth A Davison; Paul DeLucca; Howard Dittrich; Michael M Givertz; Gang Jia; George A Mansoor; Barry Massie; Daniel M Bloomfield; John G F Cleland; Gad Cotter
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
European heart journal 2011;32(12):1519-34.
2011: Adriaan A Voors; Howard C Dittrich; Barry M Massie; Paul DeLucca; George A Mansoor; Marco Metra; Gad Cotter; Beth D Weatherley; Piotr Ponikowski; John R Teerlink; John G F Cleland; Christopher M O'Connor; Michael M Givertz
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Journal of the American College of Cardiology 2011;57(19):1899-907.
2011: Adriaan A Voors; Iwan C C van der Horst
Diabetes: a driver for heart failure.
Heart (British Cardiac Society) 2011;97(9):774-80.
2011: Ali Balci; Willem Drenthen; Barbara J M Mulder; Jolien Roos-Hesselink; Adriaan A Voors; Hubert W Vliegen; Philip Moons; Krystyna M Sollie; Arie P J van Dijk; Dirk J van Veldhuisen; Petronella G Pieper
Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events.
American heart journal 2011;161(2):307-13.
2011: Rudolf A de Boer; Dirk J A Lok; Tiny Jaarsma; Peter van der Meer; Adriaan A Voors; Hans L Hillege; Dirk J van Veldhuisen
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.
Annals of medicine 2011;43(1):60-8.
2010: Christian Ukena; Felix Mahfoud; Michael Kindermann; Ingrid Kindermann; Robert Bals; Adriaan A Voors; Dirk J van Veldhuisen; Michael Böhm
The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease.
International journal of cardiology 2010;145(2):172-6.
2010: Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud W J van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
A single dose of erythropoietin in ST-elevation myocardial infarction.
European heart journal 2010;31(21):2593-600.
2010: Marco Metra; G Michael Felker; Valerio Zacà; Silvia Bugatti; Carlo Lombardi; Luca Bettari; Adriaan A Voors; Mihai Gheorghiade; Livio Dei Cas
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy.
International journal of cardiology 2010;144(2):175-9.
2010: Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.
European journal of heart failure 2010;12(10):1130-9.
2010: Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions.
European journal of heart failure 2010;12(9):895-7.
2010: Willem Drenthen; Eric Boersma; Ali Balci; Philip Moons; Jolien Roos-Hesselink; Barbara J M Mulder; Hubert W Vliegen; Arie P J van Dijk; Adriaan A Voors; Sing-Chien Yap; Dirk J van Veldhuisen; Petronella G Pieper
Predictors of pregnancy complications in women with congenital heart disease.
European heart journal 2010;31(17):2124-32.
2010: Joost P van Melle; Pieter A van der Vleuten; Yoran M Hummel; Robin Nijveldt; René A Tio; Adriaan A Voors; Felix Zijlstra
Predictive value of tissue Doppler imaging for left ventricular ejection fraction, remodelling, and infarct size after percutaneous coronary intervention for acute myocardial infarction.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2010;11(7):596-601.
2010: B Daan Westenbrink; Willem-Peter T Ruifrok; Adriaan A Voors; Ronald G Tilton; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst; Rudolf A de Boer
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Cardiovascular research 2010;87(1):30-9.
2010: Marco Metra; John G Cleland; Beth Davison Weatherley; Howard C Dittrich; Michael M Givertz; Barry M Massie; Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Gad Cotter
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
European journal of heart failure 2010;12(5):499-507.
2010: Liza S M Wong; Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Veryan Codd; B Daan Westenbrink; Germaine F J D Benus; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure.
European journal of heart failure 2010;12(4):348-53.
2010: Jasper W L Hartog; Ruud M van de Wal; Casper G Schalkwijk; Toshio Miyata; Wybren Jaarsma; H W Thijs Plokker; LM van Wijk; Andries J Smit; Dirk J van Veldhuisen; Adriaan A Voors
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
European journal of heart failure 2010;12(4):397-403.
2010: Lennaert Kleijn; Rudolf A de Boer; Adriaan A Voors
Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?
European journal of heart failure 2010;12(3):215-6.
2010: Suzan Willemsen; Jasper W L Hartog; Yoran M Hummel; Jan L Posma; LM van Wijk; Dirk J van Veldhuisen; Adriaan A Voors
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.
European journal of heart failure 2010;12(3):294-300.
2010: Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Ivonne Lesman-Leegte; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and psychological well-being in patients with chronic heart failure.
Age and ageing 2010;39(2):223-7.
2010: Pim van der Harst; Riemer H J A Slart; René A Tio; Peter H J M Dunselman; Antoon T M Willemsen; Ad F M van den Heuvel; Adriaan A Voors; Dirk J van Veldhuisen
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
The American journal of cardiology 2010;105(4):517-21.
2010: Adriaan A Voors; Ruud M A van de Wal; Jasper W L Hartog; Richard G Vijn; Yoran M Hummel; Thijs W M Plokker; Dirk J van Veldhuisen; Wybren Jaarsma
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2010;24(1):33-40.
2010: Anne M S Belonje; Adriaan A Voors; peter van der meer; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Endogenous erythropoietin and outcome in heart failure.
Circulation 2010;121(2):245-51.
2010: Olga Milo-Cotter; John R Teerlink; Marco Metra; G Michael Felker; Piotr Ponikowski; Adriaan A Voors; Christopher Edwards; Beth D Weatherley; Barry Greenberg; Gerasimos Filippatos; Elaine Unemori; Sam L Teichman; Gad Cotter
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study.
Cardiology 2010;117(3):190-6.
2010: Gad Cotter; Adriaan A Voors; Beth Davison Weatherley; Peter S Pang; John R Teerlink; Gerasimos Filippatos; Piotr Ponikowski; Olga Milo-Cotter; Howard Dittrich; Sam L Teichman; Kirkwood F Adams; Mihai Gheorghiade; Marco Metra
Acute heart failure clinical drug development: from planning to proof of activity to phase III.
Cardiology 2010;116(4):292-301.
2010: V M van Deursen; Kevin Damman; Hans L Hillege; A P van Beek; Dirk J van Veldhuisen; Adriaan A Voors
Abnormal liver function in relation to hemodynamic profile in heart failure patients.
Journal of cardiac failure 2010;16(1):84-90.
2010: Cornelis Boersma; Adriaan A Voors; Sipke T Visser; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2010;10(1):49-54.
2010: Pim van der Harst; Rudolf A de Boer; Nilesh J Samani; Liza S M Wong; Jardi Huzen; Veryan Codd; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and outcome in heart failure.
Annals of medicine 2010;42(1):36-44.
2009: Sam L Teichman; Elaine Unemori; Thomas Dschietzig; Kirk Conrad; Adriaan A Voors; John R Teerlink; G Michael Felker; Marco Metra; Gad Cotter
Relaxin, a pleiotropic vasodilator for the treatment of heart failure.
Heart failure reviews 2009;14(4):321-9.
2009: Marco Metra; John R Teerlink; Adriaan A Voors; G Michael Felker; Olga Milo-Cotter; Beth Weatherley; Howard Dittrich; Gad Cotter
Vasodilators in the treatment of acute heart failure: what we know, what we don't.
Heart failure reviews 2009;14(4):299-307.
2009: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Renal dysfunction is associated with shorter telomere length in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(10):629-34.
2009: Kevin Damman; Tiny Jaarsma; Adriaan A Voors; gerjan navis; Hans L Hillege; Dirk J van Veldhuisen
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
European journal of heart failure 2009;11(9):847-54.
2009: Richard M de Jong; René A Tio; Pim van der Harst; Adriaan A Voors; Paul M Koning; Clark J A M Zeebregts; Dirk J van Veldhuisen; Rudi A J O Dierckx; Riemer H J A Slart
Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2009;16(5):769-74.
2009: Rudolf A de Boer; Adriaan A Voors; Pieter Muntendam; Wiek H van Gilst; Dirk J van Veldhuisen
Galectin-3: a novel mediator of heart failure development and progression.
European journal of heart failure 2009;11(9):811-7.
2009: Gerard C M Linssen; Kevin Damman; Hans L Hillege; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.
Circulation 2009;120(1):35-41.
2009: Adriaan A Voors; Stephan von Haehling; Stefan D Anker; Hans L Hillege; Joachim Struck; Oliver Hartmann; Andreas Bergmann; Iain Squire; Dirk J van Veldhuisen; Kenneth Dickstein
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
European heart journal 2009;30(10):1187-94.
2009: John R Teerlink; Marco Metra; G Michael Felker; Piotr Ponikowski; Adriaan A Voors; Beth Davison Weatherley; Alon Marmor; Amos Katz; Jacek Grzybowski; Elaine Unemori; Sam L Teichman; Gad Cotter
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
Lancet 2009;373(9673):1429-39.
2009: Jasper W L Hartog; Suzan Willemsen; Adriaan A Voors
Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines".
Circulation 2009;119(10):e233; author reply e234.
2009: Kevin Damman; Vincent M van Deursen; gerjan navis; Adriaan A Voors; Dirk J van Veldhuisen; Hans L Hillege
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
Journal of the American College of Cardiology 2009;53(7):582-8.
2009: Tom D J Smilde; Kevin Damman; Pim van der Harst; gerjan navis; B Daan Westenbrink; Adriaan A Voors; Frans Boomsma; Dirk J van Veldhuisen; Hans L Hillege
Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(2):121-9.
2009: Colin J Petrie; Adriaan A Voors; Dirk J van Veldhuisen
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
International journal of cardiology 2009;131(3):336-44.
2008: Kevin Damman; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
European journal of heart failure 2008;10(10):997-1000.
2008: Jasper W L Hartog; Suzan Willemsen; Adriaan A Voors
What is the influence of renal function on the prognostic value of advanced glycation end-products and sRAGE in heart failure?
Journal of cardiac failure 2008;14(7):626; author reply 627-8.
2008: Jasper W L Hartog; Yoran M Hummel; Adriaan A Voors; Casper G Schalkwijk; Toshio Miyata; Roel M Huisman; Andries J Smit; Dirk J van Veldhuisen
Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
Journal of cardiac failure 2008;14(7):596-602.
2008: Aarnoud Hoekema; Adriaan A Voors; Peter J Wijkstra; Boudewijn Stegenga; Johannes H Van Der Hoeven; Cornelis G Tol; Lambert G M de Bont
Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides.
International journal of cardiology 2008;128(2):232-9.
2008: Adriaan A Voors; Richard M de Jong
Treating diastolic heart failure.
Heart (British Cardiac Society) 2008;94(8):971-2.
2008: B Daan Westenbrink; Hisko Oeseburg; Lennaert Kleijn; Pim van der Harst; Anne M S Belonje; Adriaan A Voors; Regien G Schoemaker; Rudolf A de Boer; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):265-74.
2008: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
The American journal of cardiology 2008;102(2):223-5.
2008: Pim van der Harst; Liza S M Wong; Rudolf A de Boer; Scott Brouilette; Gerrit van der Steege; Adriaan A Voors; Alistair Hall; Nilesh J Samani; John Wikstrand; Wiek H van Gilst; Dirk J van Veldhuisen
Possible association between telomere length and renal dysfunction in patients with chronic heart failure.
The American journal of cardiology 2008;102(2):207-10.
2008: peter van der meer; Dirk J Lok; James L Januzzi; Pieta W Bruggink-Andre de la Porte; Erik Lipsic; Jan van Wijngaarden; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
European heart journal 2008;29(12):1510-5.
2008: Anne M Belonje; Adriaan A Voors; Wiek H van Gilst; Stefan D Anker; Riemer H J A Slart; Rene A Tio; Felix Zijlstra; Dirk J van Veldhuisen
Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).
American heart journal 2008;155(5):817-22.
2008: Andries J Smit; Jasper W L Hartog; Adriaan A Voors; Dirk J van Veldhuisen
Advanced glycation endproducts in chronic heart failure.
Annals of the New York Academy of Sciences 2008;1126():225-30.
2008: B Daan Westenbrink; Rudolf A de Boer; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia in chronic heart failure: etiology and treatment options.
Current opinion in cardiology 2008;23(2):141-7.
2008: Leonardo De Luca; Alexandre Mebazaa; Gerasimos Filippatos; John T Parissis; Michael Böhm; Adriaan A Voors; Markku Nieminen; Faiez Zannad; Andrew Rhodes; Ali El-Banayosy; Kenneth Dickstein; Mihai Gheorghiade
Overview of emerging pharmacologic agents for acute heart failure syndromes.
European journal of heart failure 2008;10(2):201-13.
2008: Nic J G M Veeger; Gerald F Panday; Adriaan A Voors; Jan G Grandjean; Jan van der Meer; Piet W Boonstra
Excellent long-term clinical outcome after coronary artery bypass surgery using three pedicled arterial grafts in patients with three-vessel disease.
The Annals of thoracic surgery 2008;85(2):508-12.
2008: A M S Belonje; Rudolf A de Boer; Adriaan A Voors
Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(1):1-2.
2008: Erik Lipsic; B Daan Westenbrink; peter van der meer; Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
European journal of heart failure 2008;10(1):22-9.
2008: Willem Drenthen; Petronella G Pieper; Karin van der Tuuk; Jolien Roos-Hesselink; Elke S Hoendermis; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Sing-Chien Yap; Hubert W Vliegen; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Fertility, pregnancy and delivery in women after biventricular repair for double outlet right ventricle.
Cardiology 2008;109(2):105-9.
2007: Ruud M A van de Wal; Pim van der Harst; Wim Gerritsen; Fal van der Horst; Thijs H W Plokker; Ron T Gansevoort; Wiek H van Gilst; Adriaan A Voors
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2007;8(4):177-80.
2007: Kevin Damman; Adriaan A Voors
Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.".
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(6):403-4.
2007: Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.
European journal of heart failure 2007;9(12):1146-55.
2007: Jasper W L Hartog; Adriaan A Voors; Casper G Schalkwijk; Jean Scheijen; Tom D J Smilde; Kevin Damman; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
European heart journal 2007;28(23):2879-85.
2007: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
The American journal of cardiology 2007;100(10):1548-51.
2007: Ruud M A van de Wal; Pim van der Harst; Lodewijk J Wagenaar; Sven Wassmann; Wim J Morshuis; G Nickenig; Hendrik Buikema; H W M Plokker; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
Journal of cardiovascular pharmacology 2007;50(4):372-9.
2007: Adriaan A Voors; Colin J Petrie; Dirk J van Veldhuisen
Prognostic value of pulse pressure in heart failure.
Journal of cardiac failure 2007;13(8):694.
2007: Kevin Damman; gerjan navis; Adriaan A Voors; Folkert Asselbergs; Tom D J Smilde; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
Journal of cardiac failure 2007;13(8):599-608.
2007: Tom D J Smilde; Mike W Zuurman; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst; Gerrit van der Steege; Adriaan A Voors; Jan A Kors; Paul E de Jong; gerjan navis
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: Anne M S Belonje; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in chronic heart failure.
Congestive heart failure (Greenwich, Conn.) 2007;13(5):289-92.
2007: B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.
Current heart failure reports 2007;4(3):127-33.
2007: Kevin Damman; gerjan navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.
European journal of heart failure 2007;9(9):872-8.
2007: B Daan Westenbrink; Erik Lipsic; peter van der meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
European heart journal 2007;28(16):2018-27.
2007: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.
European journal of heart failure 2007;9(8):787-94.
2007: Rudolf A de Boer; Adriaan A Voors; Dirk J van Veldhuisen
Nebivolol: third-generation beta-blockade.
Expert opinion on pharmacotherapy 2007;8(10):1539-50.
2007: Adriaan A Voors
Vascular benefits of angiotensin receptor blockers.
Expert opinion on investigational drugs 2007;16(7):987-97.
2007: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; Willem A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Sing C Yap; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Outcome of pregnancy in women with congenital heart disease: a literature review.
Journal of the American College of Cardiology 2007;49(24):2303-11.
2007: B Daan Westenbrink; Adriaan A Voors; Dirk J van Veldhuisen
Is anemia in chronic heart failure caused by iron deficiency?
Journal of the American College of Cardiology 2007;49(23):2301-2; author reply 2302.
2007: Cornelis Boersma; George W Carides; Jarir Atthobari; Adriaan A Voors; Maarten J Postma
An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
Clinical therapeutics 2007;29(5):963-71.
2007: Pim van der Harst; Gerrit van der Steege; Rudolf A de Boer; Adriaan A Voors; Alistair Hall; Marcel J Mulder; Wiek H van Gilst; Dirk J van Veldhuisen
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
Journal of the American College of Cardiology 2007;49(13):1459-64.
2007: Iwan C C van der Horst; Adriaan A Voors; Dirk J van Veldhuisen
Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
Clinical research in cardiology : official journal of the German Cardiac Society 2007;96(4):193-5.
2007: D T Nguyen; E Citgez; Ben L van Brussel; F E E Vermeulen; H W M Plokker; Adriaan A Voors
Systolic blood pressure and cardiac mortality over 24 years after venous coronary bypass surgery.
Journal of human hypertension 2007;21(4):330-2.
2007: Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.
Drugs & aging 2007;24(12):1031-44.
2007: B Daan Westenbrink; Folkert W Visser; Adriaan A Voors; Tom D J Smilde; Erik Lipsic; gerjan navis; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
European heart journal 2007;28(2):166-71.
2006: Erik Lipsic; Regien G Schoemaker; peter van der meer; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Journal of the American College of Cardiology 2006;48(11):2161-7.
2006: Ruud M A van de Wal; Adriaan A Voors; Ron T Gansevoort
Urinary albumin excretion and the renin-angiotensin system in cardiovascular risk management.
Expert opinion on pharmacotherapy 2006;7(18):2505-20.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; A C M Schmidt; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Adriaan A Voors; Tjark Ebels; Dirk J van Veldhuisen
Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis.
Heart (British Cardiac Society) 2006;92(12):1838-43.
2006: Ruud M A van de Wal; Ron T Gansevoort; Pim van der Harst; Frans Boomsma; H W Thijs Plokker; Dirk J van Veldhuisen; Paul E de Jong; Wiek H van Gilst; Adriaan A Voors
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
Hypertension 2006;48(5):870-6.
2006: Tom D J Smilde; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Circulation 2006;114(15):1572-80.
2006: Pim van der Harst; Folkert Asselbergs; Hendrik Buikema; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting.
The American journal of cardiology 2006;98(6):751-3.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; W A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy and delivery in women after Fontan palliation.
Heart (British Cardiac Society) 2006;92(9):1290-4.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: a systematic review.
PLoS medicine 2006;3(8):e333.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: biological and clinical considerations.
Cardiovascular research 2006;71(3):443-54.
2006: Willem Drenthen; Petronella G Pieper; Nicole Zoon; Jolien Roos-Hesselink; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Krystyna M Sollie; Hubert W Vliegen; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy after biventricular repair for pulmonary atresia with ventricular septal defect.
The American journal of cardiology 2006;98(2):262-6.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; Nicole Zoon; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Tjark Ebels; Dirk J van Veldhuisen
Fertility, pregnancy, and delivery after biventricular repair for pulmonary atresia with an intact ventricular septum.
The American journal of cardiology 2006;98(2):259-61.
2006: Pim van der Harst; Adriaan A Voors; Meint Volbeda; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
The American journal of cardiology 2006;97(12):1697-701.
2006: Lilian J Meijboom; Willem Drenthen; Petronella G Pieper; Maarten Groenink; Joris A M van der Post; Janneke Timmermans; Adriaan A Voors; Jolien Roos-Hesselink; Dirk J van Veldhuisen; Barbara J M Mulder
Obstetric complications in Marfan syndrome.
International journal of cardiology 2006;110(1):53-9.
2006: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Arno Hoes; Dirk J van Veldhuisen
Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
American heart journal 2006;151(5):1012.e1-5.
2006: Erik Lipsic; peter van der meer; Adriaan A Voors; B Daan Westenbrink; Ad F M van den Heuvel; Hetty C de Boer; Anton-Jan van Zonneveld; Regien G Schoemaker; Wiek H van Gilst; Felix Zijlstra; Dirk J van Veldhuisen
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(2):135-41.
2006: Jochem Hogenhuis; Tiny Jaarsma; Adriaan A Voors; Hans L Hillege; Ivonne Lesman; Dirk J van Veldhuisen
Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
International journal of cardiology 2006;108(1):63-7.
2006: Tom D J Smilde; Hans L Hillege; gerjan navis; Adriaan A Voors; Jan Brouwer; Dirk J van Veldhuisen
Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
International journal of cardiology 2006;107(1):73-7.
2006: Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):69-73.
2006: Pim van der Harst; Tom D J Smilde; Hendrik Buikema; Adriaan A Voors; gerjan navis; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular function and mild renal impairment in stable coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):379-84.
2006: Ruud M A van de Wal; H W M Plokker; D J A Lok; F Boomsma; F A L van der Horst; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
International journal of cardiology 2006;106(3):367-72.
2006: Erik Lipsic; Adriaan A Voors; Dirk J van Veldhuisen
Serum erythropoietin levels and infarct size.
Journal of the American College of Cardiology 2006;47(2):468-9; author reply 469-70.
2005: Adriaan A Voors; Peter P van Geel; Hendrik Buikema; Margreeth Oosterga; Dirk J van Veldhuisen; Wiek H van Gilst
High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(3):145-50.
2005: Willem Drenthen; Petronella G Pieper; Martine Ploeg; Adriaan A Voors; Jolien Roos-Hesselink; Barbara J M Mulder; Hubert W Vliegen; Krystyna M Sollie; Tjark Ebels; Dirk J van Veldhuisen
Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries.
European heart journal 2005;26(23):2588-95.
2005: Willem Drenthen; Petronella G Pieper; Karin van der Tuuk; Jolien Roos-Hesselink; Adriaan A Voors; Bianca Mostert; Barbara J M Mulder; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.
European heart journal 2005;26(23):2581-7.
2005: Pim van der Harst; Lodewijk J Wagenaar; Hendrik Buikema; Adriaan A Voors; H W M Plokker; Wim J Morshuis; A Jacob Six; Piet W Boonstra; Georg Nickenig; Sven Wassmann; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
The American journal of cardiology 2005;96(10):1361-4.
2005: Ruud M A van de Wal; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?
European heart journal 2005;26(22):2361-7.
2005: Adriaan A Voors; Willem F Terpstra; Andries J Smit; Frank W Beltman; R Vijn; Pieter A de Graeff; Dirk J van Veldhuisen
Gender-related differences in left ventricular structural and functional responses to hypertension.
Journal of human hypertension 2005;19(11):915-7.
2005: Ruud M A van de Wal; Folkert Asselbergs; H W M Plokker; Tom D J Smilde; Dirk Lok; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
High prevalence of microalbuminuria in chronic heart failure patients.
Journal of cardiac failure 2005;11(8):602-6.
2005: peter van der meer; Erik Lipsic; B Daan Westenbrink; Ruud M A van de Wal; Regien G Schoemaker; Edo Vellenga; Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
Circulation 2005;112(12):1743-7.
2005: Adriaan A Voors; Colin J Petrie; Mark C Petrie; Andrew Charlesworth; Hans L Hillege; Felix Zijlstra; John J McMurray; Dirk J van Veldhuisen
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
European heart journal 2005;26(17):1759-64.
2005: Lodewijk J Wagenaar; Braim M Rahel; Ad J van Boven; Adriaan A Voors; Allard C van der Wal; H W M Plokker; Wiek H van Gilst
Pre-procedural ACE-activity does not predict symptomatic in-stent restenosis.
International journal of cardiology 2005;103(1):73-7.
2005: peter van der meer; Erik Lipsic; Robert H Henning; Kristien M Boddeus; Jolanda van der Velden; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
Journal of the American College of Cardiology 2005;46(1):125-33.
2005: J M Meijer; Petronella G Pieper; Willem Drenthen; Adriaan A Voors; Jolien Roos-Hesselink; Arie P J van Dijk; Barbara J M Mulder; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot.
Heart (British Cardiac Society) 2005;91(6):801-5.
2005: Dirk J van Veldhuisen; Adriaan A Voors
Implantable cardioverter-defibrillators.
The New England journal of medicine 2005;352(19):2022-5; author reply 2022-5.
2005: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Statins and autonomic function in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(3):167-8.
2005: peter van der meer; Rudolf A de Boer; Hazel L White; Gerrit van der Steege; Alistair Hall; Adriaan A Voors; Dirk J van Veldhuisen
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
Journal of cardiac failure 2005;11(4):279-84.
2005: Erik Lipsic; Iwan C C van der Horst; Adriaan A Voors; peter van der meer; Maarten W N Nijsten; Wiek H van Gilst; Dirk J van Veldhuisen; Felix Zijlstra
Hemoglobin levels and 30-day mortality in patients after myocardial infarction.
International journal of cardiology 2005;100(2):289-92.
2005: Adriaan A Voors; Pieter J de Kam; Maarten P van den Berg; Claudio Borghi; Judith S Hochman; Dirk J van Veldhuisen; Wiek H van Gilst
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(2):119-24.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Ruud M A van de Wal; Ben L van Brussel; Adriaan A Voors; Tom D J Smilde; Johannes C Kelder; Henry A Van Swieten; Wiek H van Gilst; Dirk Jan van Veldhuisen; H W M Plokker
Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery.
The Journal of thoracic and cardiovascular surgery 2005;129(2):330-5.
2005: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Frans Boomsma; Dirk J van Veldhuisen
Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
European journal of heart failure 2005;7(1):81-6.
2005: Bas Langeveld; Anton J M Roks; René A Tio; Adriaan A Voors; Felix Zijlstra; Wiek H van Gilst
Renin-angiotensin system intervention to prevent in-stent restenosis: an unclosed chapter.
Journal of cardiovascular pharmacology 2005;45(1):88-98.
2004: Pieter J de Kam; Adriaan A Voors; Francesco Fici; Dirk J van Veldhuisen; Wiek H van Gilst
The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(4):161-8.
2004: Pim van der Harst; Meint Volbeda; Adriaan A Voors; Hendrik Buikema; Sven Wassmann; Michael Böhm; Georg Nickenig; Wiek H van Gilst
Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting.
Hypertension 2004;44(6):930-4.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: Jochem Hogenhuis; Tiny Jaarsma; Adriaan A Voors; Dirk J van Veldhuisen
BNP and functional status in heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):507; author reply 509.
2004: Ruud M A van de Wal; Adriaan A Voors; H W M Plokker; Wiek H van Gilst; Dirk J van Veldhuisen
New pharmacological strategies in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):491-501.
2004: Adriaan A Voors; Peter P van Geel; Margreeth Oosterga; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(3):130-4.
2004: Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
The New England journal of medicine 2004;351(7):714-7; author reply 714-7.
2004: Tom D J Smilde; Hans L Hillege; Adriaan A Voors; Peter H J M Dunselman; Dirk J van Veldhuisen
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.
The American journal of cardiology 2004;94(2):240-3.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Tom D J Smilde; Wiek H van Gilst; Dirk J van Veldhuisen
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
Journal of the American College of Cardiology 2004;44(1):63-7.
2004: Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen
Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
Circulation 2004;109(5):e34; author reply e34.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in cardiovascular diseases.
European heart journal 2004;25(4):285-91.
2003: Ben L van Brussel; Adriaan A Voors; J M P G Ernst; Paul J Knaepen; H W M Plokker
Venous coronary artery bypass surgery: a more than 20-year follow-up study.
European heart journal 2003;24(10):927-36.
2003: Adriaan A Voors; Margreeth Oosterga; Hendrik Buikema; Massimo Mariani; Jan G Grandjean; Wiek H van Gilst
Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.
Journal of cardiovascular pharmacology 2003;41(2):178-84.
2002: Lodewijk J Wagenaar; Adriaan A Voors; Hendrik Buikema; Wiek H van Gilst
Angiotensin receptors in the cardiovascular system.
The Canadian journal of cardiology 2002;18(12):1331-9.
2002: Lodewijk J Wagenaar; Adriaan A Voors; Hendrik Buikema; Azuwerus van Buiten; Rob H Lübeck; Piet W Boonstra; Dirk J van Veldhuisen; Wiek H van Gilst
Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(4):311-6.
2002: Pieter J de Kam; Adriaan A Voors; Jan Brouwer; Martin St John Sutton; Wiek H van Gilst
Approaches to statistical analysis of repeated echocardiographic measurements after myocardial infarction and its relation to heart failure: Application of a random-effects model.
European journal of heart failure 2002;4(3):277-82.
2002: Pieter J de Kam; Gian Luigi Nicolosi; Adriaan A Voors; Maarten P van den Berg; Jan Brouwer; D J van Veldhuisen; S Barlera; A P Maggioni; Pantaleo Giannuzzi; Pier Luigi Temporelli; R Latini; Wiek H van Gilst
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data.
European heart journal 2002;23(7):536-42.
2001: Margreeth Oosterga; Adriaan A Voors; Yigal M Pinto; Hendrik Buikema; Jan G Grandjean; J Herre Kingma; Harry J G M Crijns; Wiek H van Gilst
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
The American journal of cardiology 2001;87(5):542-6.
2000: Pieter J de Kam; Adriaan A Voors; Maarten P van den Berg; Dirk J van Veldhuisen; Jan Brouwer; Harry J G M Crijns; C Borghi; E Ambrosioni; Judith S Hochman; T H LeJemtel; J Herre Kingma; M S Sutton; Wiek H van Gilst
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators.
Journal of the American College of Cardiology 2000;36(7):2047-53.
2000: Peter P van Geel; Yigal M Pinto; Adriaan A Voors; Hendrik Buikema; Margreeth Oosterga; Harry J G M Crijns; Wiek H van Gilst
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries.
Hypertension 2000;35(3):717-21.
2000: Margreeth Oosterga; Adriaan A Voors; Hendrik Buikema; Yigal M Pinto; H E Haber; Tjark Ebels; W J Morshuis; J Herre Kingma; Harry J G M Crijns; Wiek H van Gilst
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(1):55-60.
1998: Adriaan A Voors; Yigal M Pinto; Hendrik Buikema; H Urata; Margreeth Oosterga; G Rooks; Jan G Grandjean; D Ganten; Wiek H van Gilst
Dual pathway for angiotensin II formation in human internal mammary arteries.
British journal of pharmacology 1998;125(5):1028-32.
1998: T M Bergsma; Jan G Grandjean; Adriaan A Voors; Piet W Boonstra; P den Heyer; Tjark Ebels
Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries.
Circulation 1998;97(24):2402-5.
1997: Adriaan A Voors; Ben L van Brussel; Johannes C Kelder; H W M Plokker
Systolic blood pressure and (cardiac) mortality over 15 years after venous coronary bypass surgery.
European heart journal 1997;18(10):1670-7.
1997: Margreeth Oosterga; Adriaan A Voors; Pieter J de Kam; H Schunkert; Yigal M Pinto; J Herre Kingma; Wiek H van Gilst
Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial infarction.
Circulation 1997;95(12):2607-9.
1997: Adriaan A Voors; Margreeth Oosterga; Hendrik Buikema; Johan F May; Jan G Grandjean; Azuwerus van Buiten; Wiek H van Gilst
Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery.
Cardiovascular research 1997;34(3):568-74.
1997: Adriaan A Voors; Ben L van Brussel; Johannes C Kelder; H W M Plokker
Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation.
The American journal of cardiology 1997;79(10):1350-4.
1997: Ben L van Brussel; J M P G Ernst; N M Ernst; Hans C Kelder; Paul J Knaepen; H W M Plokker; F E E Vermeulen; Adriaan A Voors
Clinical outcome in venous coronary artery bypass grafting: a 15-year follow-up study.
International journal of cardiology 1997;58(2):119-26.
1996: Jan G Grandjean; Adriaan A Voors; Piet W Boonstra; P den Heyer; Tjark Ebels
Exclusive use of arterial grafts in coronary artery bypass operations for three-vessel disease: use of both thoracic arteries and the gastroepiploic artery in 256 consecutive patients.
The Journal of thoracic and cardiovascular surgery 1996;112(4):935-42.
1996: Ben L van Brussel; H W M Plokker; Adriaan A Voors; J M P G Ernst; Johannes C Kelder; Paul J Knaepen; F E E Vermeulen
Different clinical outcome in coronary artery bypass with single and sequential vein grafts: a fifteen-year follow-up study.
The Journal of thoracic and cardiovascular surgery 1996;112(1):69-78.
1996: Jurriën M ten Berg; Adriaan A Voors; Maarten J Suttorp; Sjef M P G Ernst; E Gijs Mast; Egbert T Bal; H W M Plokker
Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age.
The American journal of cardiology 1996;77(9):690-5.
1996: Adriaan A Voors; Ben L van Brussel; H W M Plokker; Sjef M P G Ernst; N M Ernst; E M Koomen; J G Tijssen; F E E Vermeulen
Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study.
Circulation 1996;93(1):42-7.
1995: Adriaan A Voors; J Herre Kingma; Wiek H van Gilst
Drug differences between ACE inhibitors in experimental settings and clinical practice.
Journal of cardiovascular risk 1995;2(5):413-22.
1995: Ben L van Brussel; H W M Plokker; Adriaan A Voors; J M P G Ernst; N M Ernst; Paul J Knaepen; E M Koomen; J G Tijssen; F E E Vermeulen
Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery.
European heart journal 1995;16(9):1200-6.
1993: Ben L van Brussel; H W M Plokker; Sjef M P G Ernst; N M Ernst; Paul J Knaepen; E M Koomen; J G Tijssen; F E E Vermeulen; Adriaan A Voors
Venous coronary artery bypass surgery. A 15-year follow-up study.
Circulation 1993;88(5 Pt 2):II87-92.